Meso Emerging Active

Funds bet on targeted cancer treatments

New narrative with limited coverage — still forming.

Score
0.4
Velocity
▲ 0.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

May 16, 2026
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a … Neutral

Related Articles

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

Nasdaq · May 16, 2026
Mixed

Timeline

Last UpdatedMay 16, 2026